Prokudin V Iu, Melkova O M, Karaulov A V, Porodenko N V
Biull Eksp Biol Med. 1992 Jun;113(6):606-8.
The inhibitory effect of adenosine on aggregation of human platelets activated by platelet activating factor (PAF), ADP and serotonin (5-HT) were examined using native platelets from blood of volunteers. Platelet aggregation was determined by Born's method. Effective adenosine concentrations (IC50) which had inhibited platelet aggregation were found to be 0.63 +/- 0.11, 1.47 +/- 0.31 and 0.64 +/- 0.18 microM, respectively. It was shown that 10 microM adenosine inhibited PAF-induced platelet aggregation completely. The same adenosine concentration blocked ADP- and 5-HT-induced aggregation only partially. Adenosine is physiological inhibitor of human platelet aggregation in administration of PAF, ADP and 5-HT. Specific characteristics of adenosine modulating effect on these ligands was elicited.
利用志愿者血液中的天然血小板,研究了腺苷对血小板活化因子(PAF)、二磷酸腺苷(ADP)和5-羟色胺(5-HT)激活的人血小板聚集的抑制作用。采用博恩氏法测定血小板聚集情况。发现抑制血小板聚集的有效腺苷浓度(IC50)分别为0.63±0.11、1.47±0.31和0.64±0.18微摩尔。结果表明,10微摩尔的腺苷可完全抑制PAF诱导的血小板聚集。相同浓度的腺苷仅部分阻断ADP和5-HT诱导的聚集。在PAF、ADP和5-HT作用下,腺苷是人体血小板聚集的生理抑制剂。揭示了腺苷对这些配体调节作用的特异性特征。